Immunoglobulin Light Chain Fibrillogenesis04/12/2002 - 03/31/2008 (Co-PI)
NIH/National Heart, Lung, and Blood Institute5 P01 HL68705 05
XIth International Symposium on Amyloidosis09/30/2006 - 08/31/2007 (PI)
NIH/National Diabetes & Digestive & Kidney Diseases1 R13 DK77562 01
A 2-Year Open Label Extension of the Phase II/III Study CL-903004 with NC-503 (Fibrillix) in Patients Suffering from Secondary (AA) Amyloidosis08/10/2003 - 02/28/2007 (Co-PI)
Neurochem Inc (Canada)
Equipment for Research on Amyloidosis09/01/2005 - 08/31/2006 (PI)
HHS/Health Resources and Services Administration1 C76 HF5761 01 00
A Phase Ii Trial Of A New Ther09/01/1999 - 08/31/2001 (PI)
FDA
R353 Fdr001346-01 8/31/06/01/1999 - 09/30/2000 (PI)
FDA
R392 Fdr001346-02 8/31/9806/01/1999 - 09/30/2000 (PI)
NIH